(XERS) Xeris Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Xeris Pharmaceuticals | (XERS) share price targets
Complete technical analysis of Xeris Pharmaceuticals (XERS) by charts plus indicators, forecast predictions and share price targets for Xeris Pharmaceuticals (XERS)
Xeris Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2025-05-14 View latest technical analysis
10 day averaged volume of Xeris Pharmaceuticals is 2496850
Date | Daily Closing Price | Open | High | Low | Volume |
14 Wed May 2025 | 4.64 | 4.96 | 5.02 | 4.62 | 0.951 times |
13 Tue May 2025 | 4.90 | 5.00 | 5.03 | 4.84 | 0.64 times |
12 Mon May 2025 | 4.95 | 4.94 | 5.02 | 4.70 | 1.205 times |
09 Fri May 2025 | 5.01 | 5.19 | 5.23 | 5.00 | 1.02 times |
08 Thu May 2025 | 5.16 | 4.47 | 5.28 | 4.42 | 2.086 times |
07 Wed May 2025 | 4.48 | 4.39 | 4.58 | 4.36 | 0.937 times |
06 Tue May 2025 | 4.30 | 4.57 | 4.60 | 4.26 | 1.101 times |
05 Mon May 2025 | 4.64 | 4.71 | 4.73 | 4.56 | 0.549 times |
02 Fri May 2025 | 4.71 | 4.50 | 4.77 | 4.47 | 0.877 times |
01 Thu May 2025 | 4.48 | 4.58 | 4.60 | 4.38 | 0.747 times |
My analysis of stock is bullish for shortterm, and stock might move up till 4.8 or till 5.2. Use a stoploss of 4.48 and if this stock hits its stoploss, then it can fall down till 4.15
Share price targets for Xeris Pharmaceuticals (XERS)
Target Type | Value |
Downside Target | 3.14 |
Downside Target | 3.45 |
Downside Target | 3.59 |
Downside Target | 3.78 |
Downside Target | 3.95 |
Downside Target | 4.26 |
Downside Target | 4.62 |
Upside Target | 4.77 |
Upside Target | 5.03 |
Upside Target | 5.28 |
Upside Target | 5.50 |
Upside Target | 5.97 |
Intraday share price targets for Xeris Pharmaceuticals (XERS)
Target Type | Value |
Downside Intraday Target | 4.5 |
Downside Intraday Target | 4.35 |
Upside Intraday Target | 4.91 |
Upside Intraday Target | 5.17 |
Upside Intraday Target | 4.76 |
Weekly technical analysis of Xeris Pharmaceuticals (XERS)
Date | Weekly Closing Price | Open | High | Low | Volume |
14 Wed May 2025 | 4.64 | 4.94 | 5.03 | 4.62 | 0.491 times |
09 Fri May 2025 | 5.01 | 4.71 | 5.28 | 4.26 | 1.188 times |
02 Fri May 2025 | 4.71 | 4.35 | 4.77 | 4.30 | 1.666 times |
25 Fri Apr 2025 | 4.31 | 4.04 | 4.36 | 3.95 | 3.768 times |
17 Thu Apr 2025 | 4.11 | 4.33 | 4.36 | 4.02 | 0.97 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Xeris Pharmaceuticals (XERS)
Date | Monthly Closing Price | Open | High | Low | Volume |
14 Wed May 2025 | 4.64 | 4.58 | 5.28 | 4.26 | 0.432 times |
30 Wed Apr 2025 | 4.57 | 5.48 | 5.50 | 3.81 | 0.738 times |
31 Mon Mar 2025 | 5.49 | 3.85 | 5.97 | 3.59 | 2.305 times |
28 Fri Feb 2025 | 3.83 | 3.48 | 4.10 | 3.45 | 1.05 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Xeris Pharmaceuticals (XERS)
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Xeris Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Xeris Pharmaceuticals in short term and the buy signal is strong.
Xeris Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Xeris Pharmaceuticals in short term but SELL signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Xeris Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 4.78 and Xeris Pharmaceuticals (XERS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Xeris Pharmaceuticals (XERS) stock. Volume based technical analysis of Xeris Pharmaceuticals (XERS) stock is negative.
Xeris Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Xeris Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Xeris Pharmaceuticals in short term and the buy signal is strong.
Xeris Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Xeris Pharmaceuticals in short term but SELL signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Xeris Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 4.78 and Xeris Pharmaceuticals (XERS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Xeris Pharmaceuticals (XERS) stock. Volume based technical analysis of Xeris Pharmaceuticals (XERS) stock is negative.
Xeris Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.